Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Origin of multiple myeloma found in rare stem cell

04.12.2003


Johns Hopkins Kimmel Cancer Center scientists have identified the cell likely to be responsible for the development of multiple myeloma, a cancer of the bone marrow that destroys bone tissue. The research, published in Blood online, suggests that therapies designed for long-term cure of the disease should target this stem cell, which, unlike other cells, can copy itself and differentiate into one or more specialized cell types.

In their studies to learn why multiple myeloma so often recurs following drug treatment, the investigators uncovered a rare stem cell , occurring in just one out of every 10,000 cells or less than one percent of all myeloma cells.

Working with immune system B-cells, the Johns Hopkins team found that this stem cell gives rise to the malignant bone marrow plasma cells characterized by multiple myeloma.



Current treatments target the malignant plasma cells but may not be effective on the errant multiple myeloma stem cells, allowing the cancer to recur. "Most therapies today are aimed at the cancer you can see, but to cure cancer you have to go after the cells responsible for the disease, similar to how we kill a weed by getting at its roots, not just the part above the ground," explains Richard Jones, M.D., professor and director of bone marrow transplant at the Johns Hopkins Kimmel Cancer Center. "If you cut off the flower and stem of a dandelion, it may look like it has died for a period of time, but the weed eventually will grow back. If you get the root, however, the weed does not grow back."

The scientists found the rare stem cell by looking at markers on the surface of damaged B-cells, which develop into plasma cells that cannot divide and multiply. "We know what the markers are on cancerous plasma cells and the antibodies they make, and we also know the markers on B-cells that are not cancerous. So, we went looking for a B-cell that has the same antibodies, can make copies of itself and mature into cancerous plasma cells," says William Matsui, M.D., assistant professor of oncology at the Johns Hopkins Kimmel Cancer Center.

They found that this multiple myeloma stem cell looks and acts genetically different from the plasma cell.

"Because these two cells are biologically different, we may need two therapies – one to kill the plasma cells, or the visible part of the weed; and one to kill the root – the stem cells," says Matsui. "Treatments that are directed at myeloma plasma cells are likely to produce visible results, but they will be temporary improvements unless we also target the myeloma stem cell."

Therapies for myeloma undergoing study at the Johns Hopkins Kimmel Cancer Center include antibodies that target the stem cells and drugs to make them age prematurely. Cancer stem cells have been found as the culprit in chronic myeloid leukemia, and the scientists believe the same pattern of cancer development may apply to other cancers, including breast cancer, acute myeloid leukemia and acute lymphocytic leukemia.

Multiple myeloma is the second most common blood cancer and strikes more than 14,000 Americans each year. Close to 11,000 will die from the disease.


This research was funded by the National Cancer Institute.

Other participants in this research include Carol Ann Huff, Qiuju Wang, Matthew T. Malehorn, James Barber, Yvette Tanhehco, B. Douglas Smith, and Curt I. Civin from the Johns Hopkins Kimmel Cancer Center.

Vanessa Wasta | EurekAlert!
Further information:
http://www.hopkinsmedicine.org

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Gold shines through properties of nano biosensors

17.08.2017 | Physics and Astronomy

Greenland ice flow likely to speed up: New data assert glaciers move over sediment, which gets more slippery as it gets wetter

17.08.2017 | Earth Sciences

Mars 2020 mission to use smart methods to seek signs of past life

17.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>